Interferon-α alters spectrin organization in normal and leukemic human B lymphocytes

S. S. Evans, W. C. Wang, C. C. Gregorio, T. Han, E. A. Repasky

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Interferon-α (IFN-α) regulates the growth, differentiation, and recirculation of normal and malignant B lymphocytes. In this report we examine the effects of IFN-α on the distribution of the cytoskeletal protein spectrin in peripheral blood B lymphocytes from normal donors and patients diagnosed with chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL). Exposure of normal and leukemic B cells to IFN-α in vitro was shown by immunofluorescence microscopy to cause a dose-dependent increase in the percentage of cells containing discrete focal accumulations of spectrin, ie, a single large aggregate or cap-like structure near the plasma membrane. Although the magnitude of this effect was variable among individual patient samples, in some experiments IFN-α induced a fourfold increase in the percentage of leukemic B cells exhibiting focal accumulations of spectrin. Spectrin reorganization induced by IFN-α was abrogated by the protein synthesis inhibitor cycloheximide. In addition, IFN-α increased the total cellular content of spectrin in B-CLL cells by approximately twofold to four- fold. Finally, a role for protein kinase C in mediating the effects of IFN- α on spectrin's organization is implicated by studies in which calphostin C inhibited the IFN-induced focal accumulation of spectrin. Taken together, these studies suggest that the immunomodulatory activities of IFN-α in normal and malignant B cells involve a change in the organization of the spectrin-based cytoskeleton.

Original languageEnglish (US)
Pages (from-to)759-766
Number of pages8
JournalBlood
Volume81
Issue number3
DOIs
StatePublished - 1993

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Interferon-α alters spectrin organization in normal and leukemic human B lymphocytes'. Together they form a unique fingerprint.

  • Cite this